Plasma levels of trefoil factors are increased in patients with advanced prostate cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.
| Original language | English |
|---|---|
| Journal | Clinical Cancer Research |
| Volume | 12 |
| Issue number | 3 Pt 1 |
| Pages (from-to) | 807-812 |
| Number of pages | 6 |
| ISSN | 1078-0432 |
| DOIs | |
| Publication status | Published - 2006 |
- Aged, Aged, 80 and over, Enzyme-Linked Immunosorbent Assay, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Male, Middle Aged, Peptides, Prospective Studies, Prostate-Specific Antigen, Prostatic Neoplasms, Sensitivity and Specificity, Tumor Suppressor Proteins
Research areas
ID: 1207944